Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Most

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Cardiovascular Research|December 12, 2023
miR-222 inhibits pathological cardiac hypertrophy and heart failureXiaojun Liu, Haobo Li, Margaret H Hastings, et al.
Journal of Cell Science|January 18, 2005
Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytesPatrick Most, Melanie Boerries, Carmen Eicher, et al.
The Journal of Gene Medicine|April 14, 2004
S100A1 gene transfer: a strategy to strengthen engineered cardiac graftsAndrew Remppis, Sven T Pleger, Patrick Most, et al.
Journal of Molecular and Cellular Cardiology|February 9, 2010
Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytesMirko Voelkers, Mareen Salz, Nicole Herzog, et al.
The International Journal of Cardiovascular Imaging|May 7, 2019
Comprehensive cardiac phenotyping in large animals: comparison of pressure-volume analysis and cardiac magnetic resonance imaging in pig post-myocardial infarction systolic heart failurePhilip W J Raake, Jens Barthelmes, Birgit Krautz, et al.
Interactive Cardiovascular and Thoracic Surgery|June 19, 2018
Impairment of the Akt pathway in transplanted Type 1 diabetic hearts is associated with post-transplant graft injurySevil Korkmaz-Icöz, Shiliang Li, Sivakkanan Loganathan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2021
Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunctionNuttarak Sasipong, Philipp Schlegel, Julia Wingert, et al.
Circulation|September 6, 2006
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarctionPatrick Most, Hanna Seifert, Erhe Gao, et al.
The Journal of Biological Chemistry|May 2, 2003
The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibersPatrick Most, Andrew Remppis, Cornelia Weber, et al.
Cell Calcium|August 22, 2006
S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytesMirko Völkers, Christopher M Loughrey, Niall Macquaide, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Cardiovascular Research|December 12, 2023
miR-222 inhibits pathological cardiac hypertrophy and heart failureXiaojun Liu, Haobo Li, Margaret H Hastings, et al.
Journal of Cell Science|January 18, 2005
Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytesPatrick Most, Melanie Boerries, Carmen Eicher, et al.
The Journal of Gene Medicine|April 14, 2004
S100A1 gene transfer: a strategy to strengthen engineered cardiac graftsAndrew Remppis, Sven T Pleger, Patrick Most, et al.
Journal of Molecular and Cellular Cardiology|February 9, 2010
Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytesMirko Voelkers, Mareen Salz, Nicole Herzog, et al.
The International Journal of Cardiovascular Imaging|May 7, 2019
Comprehensive cardiac phenotyping in large animals: comparison of pressure-volume analysis and cardiac magnetic resonance imaging in pig post-myocardial infarction systolic heart failurePhilip W J Raake, Jens Barthelmes, Birgit Krautz, et al.
Interactive Cardiovascular and Thoracic Surgery|June 19, 2018
Impairment of the Akt pathway in transplanted Type 1 diabetic hearts is associated with post-transplant graft injurySevil Korkmaz-Icöz, Shiliang Li, Sivakkanan Loganathan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2021
Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunctionNuttarak Sasipong, Philipp Schlegel, Julia Wingert, et al.
Circulation|September 6, 2006
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarctionPatrick Most, Hanna Seifert, Erhe Gao, et al.
The Journal of Biological Chemistry|May 2, 2003
The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibersPatrick Most, Andrew Remppis, Cornelia Weber, et al.
Cell Calcium|August 22, 2006
S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytesMirko Völkers, Christopher M Loughrey, Niall Macquaide, et al.
Pageof 11